Page last updated: 2024-09-05

sb 203580 and gw9508

sb 203580 has been researched along with gw9508 in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(gw9508)
Trials
(gw9508)
Recent Studies (post-2010) (gw9508)
3,48941,137102083

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ1
Bobbo, VCD; Engel, DF; Mendes, NF; Moura-Assis, A; Nogueira, GA; Papangelis, A; Solon, CS; Ulven, T; Velloso, LA; Zanesco, AM1

Other Studies

2 other study(ies) available for sb 203580 and gw9508

ArticleYear
Identification of potent Yes1 kinase inhibitors using a library screening approach.
    Bioorganic & medicinal chemistry letters, 2013, Aug-01, Volume: 23, Issue:15

    Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship

2013
Activation of GPR40 induces hypothalamic neurogenesis through p38- and BDNF-dependent mechanisms.
    Scientific reports, 2020, 07-06, Volume: 10, Issue:1

    Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Line; Cell Proliferation; Cell Survival; Hypothalamus; Imidazoles; Interleukin-6; Ligands; Male; Methylamines; Mice; Mice, Inbred C57BL; Models, Neurological; Neurogenesis; Neurons; p38 Mitogen-Activated Protein Kinases; Propionates; Protein Kinase Inhibitors; Pyridines; Receptors, G-Protein-Coupled

2020